News | December 10, 2025
Lilly to invest $6 billion in Huntsville manufacturing hub
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
Valorum will advance the commercialization and distribution of Armlupeg in the United States
Pharmaplan brings a pan-European footprint of locations and specialist teams, now operating within Exyte’s Biopharma & Life Sciences division
The trials, designed to assess whether semaglutide could slow cognitive decline, showed no significant difference compared to placebo in the progression of Alzheimer’s disease over two years
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
This marks Lupin’s first commercial product leveraging PrecisionSphere, a proprietary long-acting injectable (LAI) technology
Consolidated revenue from operations stood at Rs. 111.05 crore
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
The partnership aligns with the launch of Oracle Health’s next-generation electronic health record
Dragon Copilot integrates generative AI, ambient listening, and natural language processing (NLP) to capture and document care directly
Subscribe To Our Newsletter & Stay Updated
